Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival

Cancer

Volumn 83, Issue 11, 1998, Pages 2361-2369

  Hiura, Tsuyoshi ^a   Khalid, Humayun ^a   Yamashita, Hiromi ^a   Tokunaga, Yoshiharu ^a   Yasunaga, Akio ^a   Shibata, Shobu ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Astrocytic tumor; Histologic grade; Immunohistochemistry; Ki 67; Labeling index; Metallothionein; Survival

Indexed keywords

METALLOTHIONEIN;

ARTICLE; ASTROCYTOMA; CANCER GRADING; CANCER GROWTH; CANCER SURVIVAL; CELL PROLIFERATION; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASTROCYTOMA; CELL DIVISION; CHILD; CHILD, PRESCHOOL; FEMALE; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; KI-67 ANTIGEN; MALE; METALLOTHIONEIN; MIDDLE AGED; SURVIVAL RATE;

EID: 0032402184     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19981201)83:11<2361::AID-CNCR16>3.0.CO;2-N     Document Type: Article

References (40)

1. Hamer DH. Metallothionein. Ann Rev Biochem 1986;55:913-51.
2. Karin M. Metallothionein: proteins in search of function. Cell 1985;41:9-10.
3. Sato M, Bremmer I. Oxygen free radicals and metallothionein. Free Radical Biol Med 1993;14:325-37.
4. Kasahara K, Fujiwara Y, Nishio K, Ohmori T, Sugimoto Y, Komiya K, et al. Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin. Cancer Res 1991;51:3237-42.
5. Kraker A, Schmidt J, Krezoski S, Petering H. Binding of cis-dichlorodiammine platinum (II) to metallothionein in Ehrlich cells. Biochem Biophys Res Commun 1985;130:786-92.
6. Kaina B, Lohrer H, Karin M, Herrlach P. Overexpressed human metallothionein II gene protects Chinese hamster ovary cells from killing by alkylating agents. Proc Natl Acad Sci U S A 1990;87:2710-4.
7. Kelley S, Basu A, Teicher BA, Hacker MP, Hamer DH, Lazo JS. Overexpression of metallothionein confers resistance to anticancer drugs. Science 1988;241:1813-5.
8. Koropatnick J, Pearson J. Zinc treatment, metallothionein expression and resistance to cisplatin in mouse melanoma cells. Somat Cell Mol Genet 1990;16:529-37.
9. Bahnson RR, Banner BF, Ernstoff MS, Lazo JS, Cherian MG, Banerjiee D, et al. Immunohistochemical localization of metallothionein in transitional cell carcinoma of the bladder. J Urol 1991;146:1528-30.
10. Chin JL, Banerjiee D, Kadhim SA, Kontozoglou TE, Clauvin PJ, Cherian MG. Metallothionein in testicular germ cell tumors and drug resistance, clinical correlation. Cancer 1993; 72:3029-35.
11. Nartey N, Cherian MG, Banerjiee D. Immunohistochemical localization of metallothionein in human thyroid tumors. Am J Pathol 1987;129:177-82.
12. Ohshio G, Imamura T, Okada N, Wang Z, Yamaki K, Kyogoku T, et al. Immunohistochemical study of metallothionein in pancreatic carcinomas. J Cancer Res Clin Oncol 1996:122:351-5.
13. Oyama T, Takei H, Hikino T, Iino Y, Nagajima T. Immunohistochemical expression of metallothionein in invasive breast cancer in relation to proliferative activity, histology and prognosis. Oncology 1996;53:112-7.
14. Holloway AF, Stennard FA, Dziegielewska KM, Weller L, West AK. Localization and expression of metallothionein immunoreactivity in the developing sheep brain. Int J Dev Neurosci 1997;15:195-203.
15. Blaauwgeers HGT, Smitt SPAE, Delong JMBV, Troost D. Distribution of metallothionein in the central nervous system. Glia 1993;8:107-19.
16. Suzuki K, Nakajima K, Otaki N, Kimura M, Kawaharada U, Uehara K, et al. Localization of metallothionein in aged human brain. Pathol Int 1994;44:20-6.
17. Kikuchi Y, Irie M, Kasahara T, Sawada I, Terao T. Induction of metallothionein in a human astrocytoma cell line by interleukin-1 and heavy metals. FEBS Lett 1993;17:22-6.
18. Sawada J, Kikuchi Y, Shibutani M, Mitsumori K, Inoue K, Kasahara T. Induction of metallothionein in astrocytes by cytokines and heavy metals [review]. Biol Signal 1994;3:157-68.
19. Choudhuri S, Liu WL, Berman NEJ, Klaassen CD. Cadmium accumulation and metallothionein expression in brain of mice at different stages of development. Toxicol Lett 1996; 84:127-33.
20. Kramer KK, Liu J, Choudhury S, Klaassen CD. Induction of metallothionein mRNA and protein in murine astrocyte culture. Toxicol Applied Pharmacol 1996;136:94-100.
21. Nagel WW, Vallee BL. Cell cycle regulation of metallothionein in human colonic cancer cells. Proc Natl Acad Sci U S A 1995;92:579-83.
22. Tsujikawa K, Suzuki N, Sagawa K, Itoh M, Sugiyama T, Kohama Y, et al. Induction and subcellular localization of metallothionein in regenerating rat liver. Eur J Cell Biol 1994;63:240-6.
23. Cattoretti G, Becker MHG, Key G, Duchrow M, Schluter C, Galle J, et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB-1 and MIB-3) detect proliferating cells in microwave-processes formalin-fixed paraffin sections. J Pathol 1992;168:357-63.
24. Jaros E, Perry RH, Adam L, Kelly PJ, Crawford PJ, Kalbag RM, et al. Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours. Br J Cancer 1992;66:373-85.
25. Khalid H, Shibata S, Kishikawa M, Yasunaga A, Iseki M, Hiura T. Immunohistochemical analysis of progesterone receptor and Ki-67 labeling index in human astrocytic tumors. Cancer 1997;80:2133-40.
26. Maruno M, Kovach JS, Kelly PJ, Yanagihara T. Transforming growth factor-alpha, epidermal growth factor receptor, and proliferating potential in benign and malignant gliomas. J Neurosurg 1991;75:97-102.
27. Montine TJ, Vanderteenhaven JJ, Aguzzi A, Boyko OB, Dodge RK, Kern B, et al. Prognostic significance of Ki-67 proliferation index in supratentorial fibrillary astrocytic neoplasms. Neurosurgery 1994;34:674-8.
28. Kleihues P, Burger PC, Scheithauer BW. World Health Organization. Histological typing of tumours of the central nervous system. 2nd edition. Berlin: Springer-Verlag, 1993.
29. Folkman J, Merler E, Abernathy C, Williams G. Isolation of a tumor factor responsible for angiogenesis. J Exp Med 1971; 133:275-88.
30. Maxwell M, Naber SP, Wolfe HJ, Whyte TH, Galanopoulos T, Golden JN, et al. Expression of angiogenetic growth factor genes in primary human astrocytomas may contribute to their growth and progression. Cancer Res 1991;51:1345-51.
31. Sato S, Kohno K, Ono M, Sato Y, Kuwano M. Altered response to growth factors or retinoic acid in phenotypic transformation of rat kidney cells expressing human c-fos gene. Biochem Biophys Res Commun 1991;181:1273-80.
32. Asakuno K, Isono M, Wakabayashi Y, Mori T, Hori S, Kohno K, et al. The exogenous control of transfected c-fos gene expression and angiogenesis in cells implanted into rat brain. Brain Res 1995;702:23-31.
33. Andrews GK, Anamson ED, Gedamu L. The ontogeny of expression of murine metallothionein: comparison with the alpha-fetoprotein gene. Dev Biol 1984;103:294-303.
34. Panemangalore M, Banerjiee D, Onosaka S, Cherian MG. Changes in the intracellular accumulation and distribution of metallothionein in rat liver and kidney during postnatal development. Dev Biol 1983;97:95-102.
35. Bahnson RR, Becich M, Ernstoff MS, Sandlow J, Cohen MB, Williams RD. Absence of immunohistochemical metallothionein staining in bladder tumor specimens predicts response to neoadjuvant cisplatin, methotrexate and vinblastin chemotherapy. J Urol 1994;152:2272-5.
36. Kondo Y, Kuo SM, Watkins SC, Lazo JS. Metallothionein localization and cisplatin resistance in human hormone-independent prostatic tumor cell lines. Cancer Res 1995;55: 474-7.
37. Ferguson PJ. Mechanisms of resistance of human tumors to anticancer drugs of the platinum family: a review. J Otolaryngol 1995;24:142-52.
38. Satoh M, Cherian MG, Imura N, Shimizu H. Modulation of resistance to anticancer drugs by inhibition of metallothionein synthesis. Cancer Res 1994;54:5255-7.
39. Ebadi M, Iversen PL. Metallothionein in carcinogenesis and cancer chemotherapy [review]. Gen Pharmacol 1994: 25:1297-310.
40. Nagane M. Investigation of chemoresistance-related genes mRNA expression for selecting anticancer agents in successful adjuvant chemotherapy for a case of recurrent glioblastoma. Surg Neurol 1995;44:462-8.